vimarsana.com

Indian pharmaceutical giant Biocon on Friday reported a net profit of Rs 172.7 crore in the September quarter of financial year 2023-24, more than double its profit of Rs 81.8 crore in the same period of the previous year.According to the ...

Related Keywords

Australia ,Japan ,New Zealand ,Bengaluru ,Karnataka ,India ,United States ,America ,American ,Biocon Biologics ,Jonathan Hunt ,Shreehas Tambe ,Siddharth Mittal ,Biocon Biologics Ltd ,Biocon ,Manufacturing Services ,Biocon Ltd ,North America ,Emerging Markets ,Managing Director Siddharth Mittal ,North American ,Generic Formulations ,Managing Director Shreehas Tambe ,Managing Director Jonathan Hunt ,Quality Control ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.